1. Home
  2. ESPR vs BTGO Comparison

ESPR vs BTGO Comparison

Compare ESPR & BTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Logo BitGo Holdings Inc. Class A Common Stock

BTGO

BitGo Holdings Inc. Class A Common Stock

N/A

Current Price

$5.11

Market Cap

692.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ESPR
BTGO
Founded
2008
2013
Country
United States
United States
Employees
N/A
603
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
816.9M
692.3M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ESPR
BTGO
Price
$3.19
$5.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$8.75
$14.83
AVG Volume (30 Days)
16.8M
1.2M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.81
$34.41
P/E Ratio
N/A
$10.81
Revenue Growth
21.31
N/A
52 Week Low
$1.11
$4.67
52 Week High
$4.18
$15.30

Technical Indicators

Market Signals
Indicator
ESPR
BTGO
Relative Strength Index (RSI) 67.43 41.34
Support Level $3.16 $4.72
Resistance Level $3.26 $5.75
Average True Range (ATR) 0.02 0.37
MACD -0.01 0.12
Stochastic Oscillator 78.57 41.90

Price Performance

Historical Comparison
ESPR
BTGO

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About BTGO BitGo Holdings Inc. Class A Common Stock

BitGo Holdings Inc provides various offerings to its clients including multi-signature blockchain wallet solutions allowing for secure storage, trade settlement, staking solutions, and lending of digital assets. The Company also provides professional services to develop smart contracts. Its clients range from crypto-native companies that use its self-custody wallet technology to traditional financial services firms that leverage its licensed custody, staking and trading capabilities within their own products and services.

Share on Social Networks: